Blockbuster drug Humira finally faces lower-cost rivals After years of being the world's best-selling drug, Humira faces competition fr...
Blockbuster drug Humira finally faces lower-cost rivals
After years of being the world's best-selling drug, Humira faces competition from copycat versions known as biosimilars. One called Yusimry costs a $1,000 or less.
Read more on NPR
After years of being the world's best-selling drug, Humira faces competition from copycat versions known as biosimilars. One called Yusimry costs a $1,000 or less.
Read more on NPR
